Tara Spires-Jones, PhD, University of Edinburgh, Edinburgh, UK, outlines how not just neurons and synapses but the whole brain environment contribute to disease risk and how these complex interactions change throughout the disease may provide valuable insights into developing effective therapeutics for Alzheimer’s disease. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).
